Should Congress limit cost-sharing for a 30-day supply of Insulin to $35?

Health
Affordable Insulin Now Act (H.R. 6833)
This bill has Passed the House of Representatives
Bill Summary

H.R. 6833 bans the use of deductibles and limits excessive cost-sharing for Insulin attained through private health insurance issuers of individual and group plans and the Medicare prescription benefit. Starting in 2023, private health insurance issuers will cap cost-sharing for a 30-day supply of insulin at $35 or 25% of the negotiated price (with price concessions). It would also cap the cost-sharing at $35 for those receiving a 30-day supply under the Medicare prescription drug benefit. Sponsor: Representative Craig Angie (Democrat, Minnesota, District 2)
View full bill text ➔

How do you feel?

You can still save your opinion to your scorecard, but since the vote has already taken place, your opinion won't be sent to your lawmakers.
Oppose Support

Opponents say

•   "Democrats have one solution and one solution only. That is government price fixing in the drug industry, and it goes beyond insulin. Government price fixing never works and never has worked. It’s imposing federal control over the market, which basically is socializing our economy. Insulin is a problem, and we must deal with it because of the human impact and the human tragedy that comes out of the current system. So, yes, we must fix it. But we can’t fix it by making it more expensive for everyone else and potentially driving away competitive products out of the market.” Source: Senator Mike Crapo (Republican, Idaho)


•   "Recently, the House passed the Affordable Insulin Now Act (H.R. 6833), which would cap the cost of insulin at $35 per month for those enrolled in Medicare and private health insurance plans. It would be paid for by extending a pause on a Medicare Part D rebate rule. Though the Congressional Budget Office (CBO) scored the bill as fully offset, H.R. 6833 would increase total drug costs and national health expenditures, and its enactment would be a missed opportunity for lawmakers to truly lower prescription drug costs." Source: Committee for a Responsible Federal Budget

Proponents say

•     "No American should have to choose between paying for lifesaving insulin and other basic necessities like food & rent. And yet, today, all across the country, patients are risking their own lives by rationing doses or skipping treatments entirely due to the skyrocketing cost of their medications. I’m incredibly proud that, today, the House is taking action to cap out-of-pocket insulin costs at $35 per month – ensuring that insulin is affordable and accessible for millions of Americans." Source: Representative Craig Annie (Democracy, Minnesota, District 2)


•     "Congress has provided much-needed assistance to health care providers in the form of Medicare sequester relief through March 2021. This relief helped to improve what was, and continues to be, the relatively dire financial outlook for many hospitals and health systems. However, additional relief is needed. Congress should pass legislation to extend the moratorium on the Medicare sequester cuts so that hospitals and health systems can continue to care for patients, families, and communities." Source: Nancy Pelosi (Speaker of the House)

Further Reading
−  Less Information
Next Bill >

IssueVoter is a non-partisan civic engagement platform.

Sign up to make your voice count before laws pass and keep your lawmaker accountable.

  • Get alerts about bills before they pass.
  • See summaries, pros/cons, and recent news for each bill.
  • Send your opinion in 1-click.
  • Track your rep’s activity year-round.
  • Make a more informed decision at election time.
Register